White Papers

The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping traditional New Chemical Entity sectors. Emerging novel drugs show huge therapeutic potential, such...

Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. Blockchain holds significant promise to advance the digital strength of medicine supply. What is blockchain?Bob Celeste the...

The dates are confirmed, the syllabus completed and the course directors are ready to welcome you to the only MBA carefully developed for pharmaceutical leaders: the MBA Pharmaceutical Management. Combining the academic excellence of Middlesex University...

This whitepaper covers the latest pharmaceutical logistics regulatory developments around the globe such as FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more!. Get the latest on how these regulatory changes could impact your cold chain...

McKesson, Fisher BioServices, GE Healthcare and Cryoport are proud to announce our first annual workshop. Our FREE two-day workshop will provide a forum for industry experts to present and discuss current technological advancements in cryogenic management, regulatory requirements and...

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution. The importance of successfully executing a digital health strategy, as well as creating new financial...

Overcome the challenges associated with traditional affinity purification methods using Thermo Scientific™ MSIA™ (Mass Spectrometric Immunoassay) microcolumns. Designed for analytical affinity purification, ready-to-use MSIA microcolumns are coated with target-specific affinity ligand to capture low abundant target analytes from even...